drugset / Trial / NCT03217474

Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis

NCT03217474

Unknown 100 enrolled Chunxiao Wang
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to learn if adding femtosecond laser-assisted corneal debridement to a standard therapy of oral ganciclovir can help shorten the healing time of herpes simplex epithelial keratitis (HSK).

Timeline

Start
2017-07-20
Primary completion
2018-12-30
Completion
2019-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ganciclovir Small molecule 200 mg Oral